Boon L - Search Results

1

Genetics of lymphatic anomalies.

Brouillard P, Boon L, Vikkula M. Brouillard P, et al. Among authors: boon l. J Clin Invest. 2014 Mar;124(3):898-904. doi: 10.1172/JCI71614. Epub 2014 Mar 3. J Clin Invest. 2014. PMID: 24590274 Free PMC article. Review.

2

Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.

Ghalamkarpour A, Morlot S, Raas-Rothschild A, Utkus A, Mulliken JB, Boon LM, Vikkula M. Ghalamkarpour A, et al. Among authors: boon lm. Clin Genet. 2006 Oct;70(4):330-5. doi: 10.1111/j.1399-0004.2006.00687.x. Clin Genet. 2006. PMID: 16965327

3

Pathogenesis of vascular anomalies.

Boon LM, Ballieux F, Vikkula M. Boon LM, et al. Clin Plast Surg. 2011 Jan;38(1):7-19. doi: 10.1016/j.cps.2010.08.012. Clin Plast Surg. 2011. PMID: 21095468 Free PMC article. Review.

4

Vascular anomalies: from genetics toward models for therapeutic trials.

Uebelhoer M, Boon LM, Vikkula M. Uebelhoer M, et al. Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a009688. doi: 10.1101/cshperspect.a009688. Cold Spring Harb Perspect Med. 2012. PMID: 22908197 Free PMC article. Review.

5

Genetics of vascular malformations.

Nguyen HL, Boon LM, Vikkula M. Nguyen HL, et al. Semin Pediatr Surg. 2014 Aug;23(4):221-6. doi: 10.1053/j.sempedsurg.2014.06.014. Epub 2014 Jun 19. Semin Pediatr Surg. 2014. PMID: 25241102 Review.

6

Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

Boscolo E, Limaye N, Huang L, Kang KT, Soblet J, Uebelhoer M, Mendola A, Natynki M, Seront E, Dupont S, Hammer J, Legrand C, Brugnara C, Eklund L, Vikkula M, Bischoff J, Boon LM. Boscolo E, et al. Among authors: boon lm. J Clin Invest. 2015 Sep;125(9):3491-504. doi: 10.1172/JCI76004. Epub 2015 Aug 10. J Clin Invest. 2015. PMID: 26258417 Free PMC article. Clinical Trial.

7

Etiology and Genetics of Congenital Vascular Lesions.

Queisser A, Boon LM, Vikkula M. Queisser A, et al. Otolaryngol Clin North Am. 2018 Feb;51(1):41-53. doi: 10.1016/j.otc.2017.09.006. Otolaryngol Clin North Am. 2018. PMID: 29217067 Review.

8

Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation.

Martinez-Corral I, Zhang Y, Petkova M, Ortsäter H, Sjöberg S, Castillo SD, Brouillard P, Libbrecht L, Saur D, Graupera M, Alitalo K, Boon L, Vikkula M, Mäkinen T. Martinez-Corral I, et al. Among authors: boon l. Nat Commun. 2020 Jun 8;11(1):2869. doi: 10.1038/s41467-020-16496-y. Nat Commun. 2020. PMID: 32513927 Free PMC article.

9

New and Emerging Targeted Therapies for Vascular Malformations.

Van Damme A, Seront E, Dekeuleneer V, Boon LM, Vikkula M. Van Damme A, et al. Am J Clin Dermatol. 2020 Oct;21(5):657-668. doi: 10.1007/s40257-020-00528-w. Am J Clin Dermatol. 2020. PMID: 32557381 Review.

10

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.

Brouillard P, Schlögel MJ, Homayun Sepehr N, Helaers R, Queisser A, Fastré E, Boutry S, Schmitz S, Clapuyt P, Hammer F, Dompmartin A, Weitz-Tuoretmaa A, Laranne J, Pasquesoone L, Vilain C, Boon LM, Vikkula M. Brouillard P, et al. Among authors: boon lm. Orphanet J Rare Dis. 2021 Jun 10;16(1):267. doi: 10.1186/s13023-021-01898-y. Orphanet J Rare Dis. 2021. PMID: 34112235 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results